Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Biotin-HPDP for Reversible Thiol Labeling
2026-08-13
Biotin-HPDP combines thiol-selective chemistry with a cleavable biotin tag for redox profiling, S-nitrosylation studies, and affinity workflows. Its medium spacer arm supports streptavidin detection while the disulfide linkage enables controlled release after capture.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-13
Oliveira and colleagues show that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to host receptors, with particularly strong effects observed for shorter N-terminally truncated peptides. The work connects renin-angiotensin system research with viral receptor biology and provides a structure–activity framework for investigating how peptide length and tyrosine modification influence spike–receptor interactions.
-
Zosuquidar (LY335979) for MDR Research
2026-08-12
Zosuquidar (LY335979) 3HCl provides a selective way to test whether P-glycoprotein drives chemotherapy failure, rather than merely increasing drug exposure. This workflow-focused guide shows how to combine P-gp efflux pump inhibition with viability, transport, intracellular drug, and pharmacokinetic measurements.
-
Pemetrexed: A Folate–DNA Repair Assay Framework
2026-08-12
Pemetrexed disodium is more than a cytotoxic benchmark: it can anchor experiments connecting folate-dependent nucleotide stress with DNA-repair phenotypes. This article develops a decision framework for cancer chemotherapy research, with practical guidance for mesothelioma and lung tumor models.
-
Plant Cell Lysis Buffer for WB and IP
2026-08-11
Plant Cell Lysis Buffer for WB and IP (SKU K1126) is a non-denaturing extraction reagent containing 1% Triton X-100 and protease/phosphatase inhibitors. It is designed for protein sample preparation from plant cells, tissues, and protoplasts before Western blotting, immunoprecipitation, co-immunoprecipitation, PAGE, or ELISA.
-
Ruxolitinib phosphate: JAK Signaling in ATC
2026-08-11
Ruxolitinib phosphate (INCB018424) offers a precise way to interrogate JAK1/2–STAT3 biology. This article translates recent anaplastic thyroid carcinoma findings into practical, mechanism-aware assay decisions.
-
BRCAness Predicts Olaparib Response in Mesothelioma
2026-08-10
Borchert et al. linked homologous recombination repair gene-expression patterns with olaparib sensitivity in malignant pleural mesothelioma, particularly in BAP1-mutated cells. The study combines in vitro treatment experiments with expression analysis of 91 clinical samples, providing a rationale for biomarker-guided PARP inhibition while underscoring the need for clinical validation.
-
Targeted EPO mRNA Nanoparticles for SCI Repair
2026-08-09
A 2026 Materials Today Bio study developed mannose-modified lipid nanoparticles to deliver EPO mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, the approach improved lesion-localized EPO expression, reduced neuroinflammation and ferroptosis-associated damage, and enhanced motor recovery, while highlighting the importance of targeted delivery for mRNA-based neurorepair.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-08-08
Lambda Protein Phosphatase provides a practical dephosphorylation control for testing whether BMAL1 phosphorylation influences antibody recognition, transcriptional activity, or condensate behavior. This workflow connects the 2026 BMAL1 phase-separation findings with reproducible phosphorylation analysis while emphasizing controls, buffer compatibility, and troubleshooting.
-
MDL 28170: A Mechanism-to-Assay Guide
2026-08-07
MDL 28170 is a selective calpain inhibitor that connects cysteine protease biology with rigorous neuroprotection research. This guide translates recent BDNF/TrkB findings into practical assay decisions while defining how far evidence can be extended across injury, cardiac, and infection models.
-
Zosuquidar (LY335979): Optimizing P-gp Inhibition in MDR Can
2026-08-07
Zosuquidar (LY335979) 3HCl enables robust, selective reversal of P-glycoprotein-mediated multidrug resistance in cancer research. This article delivers actionable workflows, performance data, and troubleshooting insights to maximize drug sensitization and experimental reproducibility using APExBIO's trusted formulation.
-
ZDHHC4-Mediated Palmitoylation Regulates TRPV1 and Inflammat
2026-08-06
This study reveals that the palmitoyl acyltransferase ZDHHC4 directly palmitoylates TRPV1, targeting specific cysteine residues and promoting its lysosomal degradation. These findings clarify a novel regulatory mechanism underlying the relief phase of inflammatory pain and suggest new avenues for modulating nociception through post-translational modification.
-
OsALY4: An m5C-mRNA Reader Enhancing Stress Tolerance in Ric
2026-08-06
Gao et al. identify OsALY4 as a key m5C-mRNA reader that facilitates the nuclear export of methylated mRNAs, directly enhancing chilling and salt tolerance in rice. This discovery uncovers a new mechanistic layer in plant adaptation to abiotic stress and provides a foundation for further translational research in crop resilience.
-
Biotin-HPDP: Precision Thiol Labeling for Redox Proteomics
2026-08-05
Biotin-HPDP enables precise, reversible thiol-specific protein labeling, driving advanced detection of dynamic post-translational modifications and affinity purification. Its unique chemistry empowers translational researchers to dissect redox signaling and membrane localization events pivotal in immune response and neurodegeneration.
-
Iron-Dependent KDM4D Activity Regulates MSC Quiescence via P
2026-08-05
This study uncovers how iron-dependent KDM4D activity modulates the activation of mesenchymal stem cells (MSCs) by orchestrating chromatin changes at the PIK3R3 promoter, thereby regulating the PI3K-Akt-Foxo1 pathway. The findings illuminate a mechanistic link between iron deficiency, stem cell quiescence, and bone loss, with clear implications for bone metabolism research and targeted pharmacological intervention.